
Director, Pediatric Leukemia/Lymphoma @ATL peds; Professor@EmoryMed; Lymphoma; Survivorship/Outcomes; Reducing Disparities; #WomenInMedicine. Views are my own.
Atlanta, GA
Joined September 2016
- Tweets301
- Following258
- Followers304
- Likes1.6K
Sharon M. Castellino retweeted
Research takes time. For children facing cancer, there’s no time to waste.
After losing his son Andrew to leukemia, Joe McDonough made supporting research his mission. For Joe and all of us at COG, every advance matters because every child matters.
childrensoncologygroup.org/b…
Sharon M. Castellino retweeted
Every advance in childhood cancer research matters. Our goal: every child survives and thrives.
As Awareness Month ends, stay involved. Read our reflection, sign up for occasional updates, or explore ways to give.
childrensoncologygroup.org/b…
Sharon M. Castellino retweeted
Childhood cancer can hide behind common symptoms. When should pediatricians look beyond the usual diagnosis? Review key red flags, case examples, and take-home lessons for primary care.
hubs.li/Q04xftD00
Sharon M. Castellino retweeted
College football fans, donate to @childrensatl during the 10th annual Touchdowns for Children's fundraising campaign! 🏈 Every time your college football team scores a touchdown during the regular season, a donation will go back to our patients. choa.org/about-us/newsroom/1…
Sharon M. Castellino retweeted
Decades of research have given more children the chance to grow up. But some children still need better treatment options, and many survivors face lifelong side effects.
We celebrate every step forward while continuing to pursue safer, more effective treatments for every child.
Sharon M. Castellino retweeted
Research changes what's possible. Every donation helps fuel the clinical trials, scientific discoveries, and collaborations bringing better treatments to children and adolescents with cancer.
Join us in making a difference.
childrensoncologygroup.org/w…
Sharon M. Castellino retweeted
We hope you’ve enjoyed learning about some of the exciting changes happening at COG. As we continue to reveal what’s changing, our purpose remains the same. Our mission, our vision, and our unwavering commitment to Turning Findings into Futures.
Sharon M. Castellino retweeted
For 25 years, COG’s network has relentlessly focused on advancing research & improving outcomes for children & adolescents.
Our mission continues as we turn findings into futures.
Sharon M. Castellino retweeted
May is National Cancer Research Month. This year, the AACR is highlighting the theme “United by Cancer Research.” Throughout May, COG will share stories that show how our global network unites experts and institutions to drive breakthroughs in pediatric oncology research.
Sharon M. Castellino retweeted
In 2024, a trial focused on improving treatment for the most common pediatric cancer was closed 2 years early thanks to collaboration across the COG network. That speed matters to kids with B-cell Acute Lymphoblastic Leukemia, a rapidly progressing cancer.
bit.ly/4spOyhb
Sharon M. Castellino retweeted
Since 1998, @hopeonwheels has supported the infrastructure behind COG’s life-changing research. From biospecimen storage to clinical trial support, their investment helps advance new treatments and better outcomes for pediatric cancer patients.
thecogfoundation.org/hyundai…
Sharon M. Castellino retweeted
Our own Dr. @SharonCastelli2 and Dr. Kara Kelly of @RoswellPark published teen cohort results from a landmark phase 3 clinical trial confirming the benefit of a nivolumab combo for advanced Hodgkin lymphoma in @JCO_ASCO. Learn more: choa.org/about-us/newsroom/r….
Sharon M. Castellino retweeted
What happens when patient advocates, healthcare leaders, and AI innovators unite? Magic, and a healthy discussion that drives real innovation.
At our Patient Advocacy AI Innovation Lab at #ASH2025, 60% of attendees already use AI tools in their work, yet 54% worry about reliability in cancer care. This tension is where breakthroughs happen.
Three key insights emerged:
1) Advocates are essential guides. As Meghan Gutierrez from @lymphoma said: "Meet patients where they are—even if they arrive before we do." Those on the front lines know what will work.
2) Trust must be earned. Verification, transparency, and human oversight aren't optional—they're fundamental.
3) Cross-industry innovation sparks breakthrough thinking. Case studies from Disney, Expedia, and Lemonade helped us reimagine patient onboarding, treatment planning, and friction reduction—while keeping human connection at the center.
This is just the beginning. Thank you to our speakers and every advocate who challenged us to think differently.
Together, we're ensuring AI serves humanity in the fight against blood cancer.
Sharon M. Castellino retweeted
Interested in learning about the latest topics in pediatric hematology? Our team will be attending and presenting on a variety of topics at @ASH_hematology's 67th Annual Meeting and Exposition, from December 6-9 in Orlando. Learn more: bit.ly/4pEBKmV. #ASH25
Sharon M. Castellino retweeted
Our @JNCI_Now study shows that receiving survivorship care plan, embedded in a comprehensive survivorship program, is associated with improved survival among childhood cancer survivors. @SharonCastelli2 @DrEffinger @JordanGMarchak @WinshipAtEmory @ATLPedsHemOnc @EmoryPediatrics
A new study led by researchers at Winship and @childrensatl shows that childhood cancer survivors who engage in long-term survivorship programs and receive a personalized survivorship care plan live longer than those who do not.
Read more ➡️ brnw.ch/21wWI7a
Sharon M. Castellino retweeted
At @BloodCancerUtd, we're all about the Accelerating Kids' Access to Care Act, so kids with cancer can be about everything else. Watch to learn more about the bill and how it can help kids with cancer ⬇️
Sharon M. Castellino retweeted
The #COGF Newsletter - Summer 2025 is here! This edition covers liquid biopsies, coordinating clinical trials, B+ Foundation philanthropic support, & an interview w/ AYA Chair, Mike Roth. thecogfoundation.org/news.ht…
Sharon M. Castellino retweeted
Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826 | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JCO…
Sharon M. Castellino retweeted
Kids with cancer deserve a chance to thrive. But in December, Congress missed a key opportunity to extend programs that incentivize drug companies to find them cures. Learn more about the Give Kids a Chance Act, and how it can help children with cancer ⬇️
statnews.com/2025/04/07/fda-…


























